Periodic Reporting for period 2 - GreenX4Drug (Green Enantioselective Halogenation for Drug Discovery and Manufacture)

Issue Addressed: The European pharmaceutical industry confronts challenges such as patent expirations and stricter environmental regulations, prompting a shift towards sustainable practices. GreenX4Drug has tackled these issues by pioneering eco-friendly methodologies for...